SUDARSHAN CHEMICAL INDUSTRIES LTD.

Sudarshan Chemical Industries Limited has announced the sale of its step-down subsidiary, VP4 Frankfurt GmbH, to Celanese Corporation, USA. VP4 Frankfurt is primarily engaged in the manufacture of Diketene as a tolling operator for Nutrinova, an affiliate of Celanese. This divestment is part of Sudarshan's strategy to sharpen its focus on its core pigments business. The transaction is expected to strengthen Sudarshan's strategic focus and operational position. Nutrinova will continue to supply Sudarshan with necessary materials post-transaction. Rajesh Rathi, Chairman & Managing Director, stated the sale aligns with the company's value creation in pigments and colorants.

Sudarshan Chemical Industries Ltd. announced the execution of a Share Purchase and Transfer Agreement for the sale of its 100% stake in VP4 Frankfurt GmbH, a step-down wholly-owned subsidiary, to Celanese US Holdings LLC. The transaction, valued at EUR 76,500,000, is expected to sharpen the company's focus on its core pigment business. VP4 Frankfurt, primarily a tolling operator for intermediates, contributed EUR 15,722,521 (6.71% standalone, 1.64% consolidated revenue) and had a net worth of EUR 5,670,674 as of March 31, 2026. The sale is subject to customary closing conditions and is not considered a related party transaction or part of a scheme of arrangement. The completion date is pending fulfillment of conditions precedent.

Sudarshan Chemical Industries Ltd has announced the launch of a new product, Sudaperm Violet 3040C, effective August 27, 2026. This product falls under the category of High-Performance Pigments and is available for both domestic and international markets, with global availability. The company stated that this launch does not trigger the materiality threshold as per SEBI Listing Regulations, but is being announced as a measure of good corporate governance. The details are also available on the company's website.

Sudarshan Chemical Industries, through its European subsidiary Sudarshan Switzerland SLO AG, has signed a definitive agreement to acquire Clariant Additives (Switzerland) AG's aluminium dyes and chemicals manufacturing plant in Muttenz, Switzerland. This plant has historically produced Sudarshan's Aluminium Dyes portfolio, including brands like Sanodal®, Sanodure®, Sanodye®, and Anodal®. The acquisition aims to secure long-term continuity for these products and enhance Sudarshan's control over the complex manufacturing process. The transaction is expected to be completed around January 4, 2027, subject to customary conditions. This move allows Sudarshan to directly own and manage the production of its key colorant portfolio, fostering future innovation and capacity planning.

Sudarshan Chemical Industries Ltd, through its step-down subsidiary Sudarshan Switzerland SLO AG, has entered into a definitive Asset Sale and Transfer Agreement with Clariant Additives (Switzerland) AG to acquire its aluminium dyes and chemicals manufacturing plant in Muttenz, Switzerland. The acquisition includes the plant that has historically manufactured Sudarshan's Aluminium Dyes portfolio, including brands like Sanodal®, Sanodure®, Sanodye®, and Anodal®. This move aims to convert a supply relationship into direct ownership. The transaction is valued at a base price of seven million Swiss Francs (CHF 7,000,000) plus inventory value, and is subject to customary conditions precedent. This acquisition is expected to strengthen Sudarshan's global presence in the aluminium dyes segment, which are crucial colorants for anodized aluminium used in automotive, consumer electronics, and packaging.

Sudarshan Chemical's consolidated (primary basis) Q1 FY27 profit for the quarter rose to ₹103.4 Cr from ₹55.0 Cr a year ago (+88% YoY; owners' share ₹97.3 Cr vs ₹47.2 Cr, +106%), on revenue of ₹2,642.1 Cr, up a modest 5.4% YoY but down 5.3% QoQ from ₹2,789.9 Cr — the QoQ dip is a sequential normalisation off a strong March-quarter order push rather than a fresh demand signal, and is not the headline here since YoY is the primary read. Net margin expanded to ~3.9% from 2.2% a year ago, and segment EBITDA margin (per the Part II disclosure) improved to ~9.8% (₹258.8 Cr) from 7.7% (₹192.4 Cr), helped by cost of materials falling to ~51.6% of revenue from ~54.9% and a ₹6.1 Cr higher joint-venture profit contribution (₹13.2 Cr vs ₹7.1 Cr). No exceptional items hit either period, so reported and adjusted growth are the same — but the print absorbed ₹36.1 Cr of Heubach-related integration and restructuring costs embedded in opex, meaning underlying margin progress would look even stronger excluding that drag. The standalone (India-only) entity tells a different story and the divergence is material: standalone revenue actually grew faster than consolidated at 27.5% YoY (₹677.4 Cr vs ₹531.2 Cr), yet standalone PAT fell 21% YoY to ₹57.8 Cr from ₹73.3 Cr. The gap is explained by a ₹62.6 Cr unfavourable foreign-exchange swing embedded in other expenses (a ₹5.7 Cr loss this quarter versus a ₹56.9 Cr gain in the year-ago quarter) — stripping that swing out, standalone opex growth (~19%) tracked broadly with revenue growth. Readers comparing the two statements should treat consolidated as the operative number; the standalone decline is a forex-timing effect, not a demand or cost-structure deterioration. On guidance: management's last concall projected Heubach EBITDA of $35 million for FY27 and $90-100 million over 3-4 years, with near-term demand described as cautiously watched given geopolitical uncertainty; this filing does not break out Heubach-specific quarterly EBITDA (only Pigments/Others segments are disclosed), so progress against that specific target cannot be verified from the statement itself — treated as unknown rather than assumed met. No management press release or commentary beyond the regulatory board-outcome letter was available for this filing, and no analyst consensus figure for this specific quarter's revenue or PAT could be sourced, so the print is also unscored against Street. Alongside results, the Board also approved in-principle internal restructuring to directly acquire the Company's existing 70.26% indirect stake in Sudarshan Colorants India Limited (formerly Heubach Colorants India) from intermediate Europe/Switzerland holding entities — a related-party, arm's-length, cash-funded reorganisation with no announced price or timeline and no control or operational impact, so no P&L effect this quarter.

Sudarshan Chemical Industries Ltd announced the outcome of its Board Meeting held on August 12, 2026. The board approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. Additionally, the company received in-principle approval for the acquisition of 70.26% equity shares in its step-down subsidiary, Sudarshan Colorants India Limited, from its existing wholly-owned subsidiaries. This move is part of an internal restructuring to directly hold shares in the target company. The trading window for securities will reopen on August 15, 2026.

Sudarshan Chemical Industries Ltd's Board of Directors has approved the in-principle acquisition of 1,62,16,847 Equity Shares, representing 70.26% of the total shareholding, in its step-down subsidiary, Sudarshan Colorants India Limited. This acquisition is part of an internal restructuring to hold the shareholding directly within the parent company. The board also approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. The transaction is subject to compliance with extant regulations, and a committee has been authorized to approve the acquisition in tranches. This restructuring will not impact the control or business operations of Sudarshan Colorants India Limited.

Sudarshan Chemical Industries Ltd has announced its recommendation for a final dividend of ₹5.00 per equity share, representing 250% of the face value of ₹2.00 each, for the financial year ended March 31, 2026. This dividend is subject to shareholder approval at the 75th Annual General Meeting scheduled for August 18, 2026. The record date for determining eligible shareholders is August 11, 2026. The company also provided details on Tax Deducted at Source (TDS) applicable to dividend payments for both resident and non-resident shareholders, outlining various rates and documentation requirements based on shareholder categories and compliance with the Income Tax Act.

Sudarshan Chemical Industries Ltd has announced that its Board of Directors will convene on August 12, 2026, to consider and approve the unaudited financial results for both standalone and consolidated operations for the first quarter ended June 30, 2026. The company will subsequently intimate these results to the stock exchanges. Additionally, the trading window for designated persons and their immediate relatives will remain closed from July 1, 2026, until 48 hours after the announcement of the financial results, expected to be August 14, 2026. This information is also available on the company's website.